• Home
  • VONVENDI: von Willebrand factor (Recombinant)

VONVENDI: von Willebrand factor (Recombinant)

  • 16 May 2019
  • 6:00 PM


[von Willebrand Factor (Recombinant)]

Shire would like to invite you to a program about VONVENDI, the first and only recombinant treatment made precisely for von Willebrand disease. This program will provide an opportunity to learn from our guest speaker, an expert in VWD.

Additional Details

Copyright 2020, Missouri Society of Health-System Pharmacists
501(c)6 non-profit organization. 2650 S. Hanley Rd., Suite 100, St. Louis, MO 63144 
p: (314) 416-2246, f: (314) 845-1891, www.moshp.org
Powered by Wild Apricot Membership Software